Comparison of 5-FU vs capecitabine in combination with mitomycin or cisplatin in the treatment of anal cancer.

被引：0
|
作者：
Yu, Irene
Cheung, Winson Y.
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.3576
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3576
引用
收藏
页数：5
相关论文
共 50 条
  • [41] Efficacy and feasibility of paclitaxel and cisplatin combination chemotherapy for the treatment of 5-flurouracil (5-FU) refractory advanced gastric cancer
    Kim, Yong Tai
    Shon, JooHyuk
    Kyu, Park Byong
    Hun, Lee Sang
    Rha, Sun Young
    Kim, Joo Hang
    Chung, Hyun Cheol
    ANNALS OF ONCOLOGY, 2006, 17 : 312 - 313
  • [42] Oxaliplatin/capecitabine vs oxaliplatin/infusional 5-FU in advanced colorectal cancer: the MRC COIN trial
    A Madi
    D Fisher
    R H Wilson
    R A Adams
    A M Meade
    S L Kenny
    L L Nichols
    M T Seymour
    H Wasan
    R Kaplan
    T S Maughan
    British Journal of Cancer, 2012, 107 : 1037 - 1043
  • [43] In-vitro effect of a combination of 5-fluorouracil (5-FU) and cisplatin (CDDP) on human gastric cancer cell lines: Timing of cisplatin treatment
    Cho H.
    Imada T.
    Oshima T.
    Shiozawa M.
    Rino Y.
    Takanashi Y.
    Gastric Cancer, 2002, 5 (1) : 43 - 46
  • [44] Oxaliplatin/capecitabine vs oxaliplatin/infusional 5-FU in advanced colorectal cancer: the MRC COIN trial
    Madi, A.
    Fisher, D.
    Wilson, R. H.
    Adams, R. A.
    Meade, A. M.
    Kenny, S. L.
    Nichols, L. L.
    Seymour, M. T.
    Wasan, H.
    Kaplan, R.
    Maughan, T. S.
    BRITISH JOURNAL OF CANCER, 2012, 107 (07) : 1037 - 1043
  • [45] COMBINATION CHEMOTHERAPY OF CISPLATIN AND 5-FU IN ADVANCED COLORECTAL-CARCINOMA
    DY, C
    GIL, A
    ALGARRA, SM
    APARICIO, LA
    CALVO, F
    HERRANZ, P
    CANCER TREATMENT REPORTS, 1986, 70 (04): : 465 - 468
  • [46] Pilot study of postoperative adjuvant chemoradiation for advanced gastric cancer:Adjuvant 5-FU/cisplatin and chemoradiation with capecitabine
    Hyung-SikLee
    YoungminChoi
    Won-JooHur
    Hyo-JinKim
    Hyuk-ChanKwon
    Sung-HyunKim
    Jae-SeokKim
    Jong-Hoon Lee
    Ghap-JoongJung
    Min-ChanKim
    World Journal of Gastroenterology, 2006, (04) : 603 - 607
  • [47] Pilot study of postoperative adjuvant chemoradiation for advanced gastric cancer: Adjuvant 5-FU/cisplatin and chemoradiation with capecitabine
    Lee, Hyung-Sik
    Choi, Youngmin
    Hur, Won-Joo
    Kim, Hyo-In
    Kwon, Hyuk-Chan
    Kim, Sung-Hyun
    Kim, Jae-Seok
    Lee, Jong-Hoon
    Jung, Ghap-Joong
    Kim, Min-Chan
    WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (04) : 603 - 607
  • [48] A systematic review of the safety profile of bolus, continuous infusion of 5-fu and capecitabine in combination with oxaliplatin in the treatment of colorectal cancer patients
    Chiara, B.
    Zichi, C.
    Di Maio, M.
    Sonetto, C.
    Brizzi, M. P.
    Scagliotti, G. V.
    Tampellini, M.
    ANNALS OF ONCOLOGY, 2016, 27
  • [49] ADXS11-001 Lm-LLO Immunotherapy, Mitomycin, 5-fluorouracil (5-FU) and Intensity modulated radiation therapy (IMRT) for Anal Cancer.
    Safran, Howard
    Leonard, Kara Lynne
    DiPetrillo, Thomas A.
    Klipfel, Adam
    Schechter, Steven
    Oldenburg, Nicholas
    Vrees, Matthew
    Roth, Leslie
    Shah, Nishit
    Mantripragada, Kalyan C.
    Rosati, Kayla
    Rajdev, Lakshmi
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [50] Protracted infusional 5FU+mitomycin in 5FU-resistant colorectal cancer.
    Chester, JD
    Dent, JT
    Wilson, G
    Ride, E
    Seymour, MT
    BRITISH JOURNAL OF CANCER, 1999, 80 : 55 - 55
12345